Catalyst Wire Dossier Catalyst Wire Dossier

HEMOLEVEN

Factor XI concentrate · Laboratoire Français de Fractionnement et de Biotechnologies (LFB)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HEMOLEVEN, covering 2013-08-23 to 2013-08-23. Get the full timeline:

Most recent: Clinical Trial Update: HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency

See pricing